
Annabidiol Corp.
OTC:ACBD
0.71 (USD) • At close November 13, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.002 | 0 | 0 | 0 | 0.055 | 0.02 | 0 | 0 |
Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.002 | 0 | 0 | 0 | 0.055 | 0.02 | 0 | 0 |
Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 0.116 | 0.003 | 0.007 | 0.004 | 0.003 | 0.002 | 0.007 | 0.008 | 0.001 | 0.002 | 0.006 | 0.007 | 0.003 | 0 | 0.007 | 0 |
Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 0.116 | 0.003 | 0.007 | 0.004 | 0.003 | 0.002 | 0.007 | 0.008 | 0.001 | 0.002 | 0.006 | 0.007 | 0.003 | 0 | 0.007 | 0 |
Operating Income
| -0.116 | -0.003 | -0.007 | -0.004 | -0.003 | -0.002 | -0.007 | 0.002 | 0 | -0.002 | -0.006 | -0.007 | 0.052 | 0.02 | -0.007 | -0 |
Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.187 | 0.107 | 0 | 0 | 0 | 0.943 | 0.98 | 0 | 0 |
Total Other Income Expenses Net
| 0 | 0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 |
Income Before Tax
| -0.116 | -0.003 | -0.007 | -0.004 | -0.003 | -0.002 | -0.007 | 0.002 | 0 | -0.002 | -0.006 | -0.007 | 0.052 | 0.02 | -0.007 | -0 |
Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.187 | 0.103 | 0 | 0 | 0 | 0.943 | 0.979 | 0 | 0 |
Income Tax Expense
| 0 | 0 | 0 | -0.043 | -0.044 | 0.04 | -0.122 | -0.042 | -0.055 | -0.027 | -0.086 | 0 | 0 | 0 | 0 | 0 |
Net Income
| -0.116 | -0.003 | -0.007 | -0.004 | -0.003 | -0.002 | -0.007 | 0.002 | 0 | -0.002 | -0.006 | -0.007 | 0.052 | 0.02 | -0.007 | -0 |
Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.187 | 0.103 | 0 | 0 | 0 | 0.943 | 0.979 | 0 | 0 |
EPS
| -0.003 | -0 | -0 | -0 | -0 | 0 | -0 | 0 | 0 | 0 | -0 | -0 | 0.001 | 0.001 | -0 | 0 |
EPS Diluted
| -0.003 | -0 | -0 | -0 | -0 | 0 | -0 | 0 | 0 | 0 | -0 | -0 | 0.001 | 0.001 | -0 | 0 |
EBITDA
| -0.116 | -0.003 | -0.007 | -0.004 | -0.003 | -0.002 | -0.007 | 0.002 | 0 | -0.002 | -0.006 | -0.007 | 0.052 | 0.02 | -0.007 | -0 |
EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.187 | 0.107 | 0 | 0 | 0 | 0.943 | 0.979 | 0 | 0 |